A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s). Top holdings included MRTX. Confidential Treatment Requested (one or more holding(s) omitted).
Filing 2016 Q3 compared to 2016 Q2 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Jason C. Callender
Director
Nassau, Bahamas
14 Nov 2016
Information with respect to which the Institutional Investment Manager is requesting Confidential Treatment has been omitted and filed separately with the Securities and Exchange Commission.
List of Other Managers Reporting for Aviva Holdings Ltd.:
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.